Risk of tuberculosis in patients treated with TNF-{alpha} antagonists: a systematic review and meta-analysis of randomised controlled trials
Conclusions
Findings from our meta-analysis indicate that the risk of TB may be significantly increased in patients treated with TNF-α antagonists. However, further studies are needed to reveal the biological mechanism of the increased TB risk caused by TNF-α antagonists treatment.
Source: BMJ Open - Category: Journals (General) Authors: Zhang, Z., Fan, W., Yang, G., Xu, Z., Wang, J., Cheng, Q., Yu, M. Tags: Open access, Evidence based practice, Infectious diseases, Pharmacology and therapeutics, Rheumatology Research Source Type: research
More News: Arthritis | Databases & Libraries | Drugs & Pharmacology | Enbrel | Endemics | General Medicine | Humira | Infectious Diseases | Remicade | Rheumatoid Arthritis | Rheumatology | Study | Tuberculosis | Warnings